Literature DB >> 19390900

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Ross A Abrams1, Andrew M Lowy, Eileen M O'Reilly, Robert A Wolff, Vincent J Picozzi, Peter W T Pisters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19390900     DOI： 10.1245/s10434-009-0413-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  83 in total

Review 1.  The role of radiotherapy in locally advanced pancreatic carcinoma.

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

Review 2.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Current treatment options for pancreatic carcinoma.

Authors:  Emily Castellanos; Jordan Berlin; Dana Backlund Cardin
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  First reported case of intentional use of a duodenal stent to treat gastric outlet obstruction prior to pancreaticoduodenectomy in a patient with pancreatic cancer.

Authors:  Sarah Ahmad; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

5.  Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.

Authors:  Federico Selvaggi; Giuseppe Mascetta; Despoina Daskalaki; Marco dal Molin; Roberto Salvia; Giovanni Butturini; Carlo Cellini; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

6.  Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.

Authors:  Samhita Chakraborty; Monica M Morris; Todd W Bauer; Reid B Adams; Edward B Stelow; Gina Petroni; Hanna K Sanoff
Journal:  Gastrointest Cancer Res       Date:  2014-01

7.  Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.

Authors:  Vikas Dudeja; Edward W Greeno; Sidney P Walker; Eric H Jensen
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

8.  Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?

Authors:  Sam G Pappas; Kathleen K Christians; Parag P Tolat; Alan P Mautz; Alysandra Lal; Lisa McElroy; T Clark Gamblin; Kiran K Turaga; Susan Tsai; Beth Erickson; Paul Ritch; Douglas B Evans
Journal:  HPB (Oxford)       Date:  2013-03-15       Impact factor: 3.647

9.  Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer.

Authors:  Walid L Shaib; Amit Surya Narayan; Jeffrey M Switchenko; Sujata R Kane; Christina Wu; Mehmet Akce; Olatunji B Alese; Pretesh R Patel; Shishir K Maithel; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes
Journal:  Cancer       Date:  2018-11-20       Impact factor: 6.860

Review 10.  Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.

Authors:  Pierluigi di Sebastiano; Tommaso Grottola; F Francesco di Mola
Journal:  Updates Surg       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.